CIK 0001367083 · Non-accelerated filer<br>Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680423298
- Phone
- 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-14 | Trombly Amy Moss Chief Executive Officer | Grant or award · Stock option (right to buy) | +30,000 | 73,648 | ||
| 2022-01-14 | Thornton Bruce COO | Grant or award · Stock option (right to buy) | +30,000 | 76,781 | ||
| 2022-01-14 | MCLAUGHLIN JOHN Director | Grant or award · Stock option (right to buy) | +30,000 | 33,252 | ||
| 2022-01-14 | DVONCH JEROME J Chief Financial Officer | Grant or award · Stock option (right to buy) | +30,000 | 57,777 | ||
| 2022-01-14 | Birnbaum Jay E Director | Grant or award · Stock option (right to buy) | +30,000 | 32,904 | ||
| 2021-01-07 | Thornton Bruce COO | Grant or award · Stock option (right to buy) | +27,777 | 47,377 | ||
| 2021-01-07 | DVONCH JEROME J Chief Financial Officer | Grant or award · Stock option (right to buy) | +27,777 | 27,777 | ||
| 2021-01-07 | Trombly Amy Moss Chief Executive Officer | Grant or award · Stock option (right to buy) | +27,777 | 43,648 | ||
| 2020-04-23 | Edwards Robert Grant Chief Financial Officer | Grant or award | +2,609 | 2,609 | ||
| 2020-04-23 | Dal Poggetto John Chief Financial Officer | Grant or award | +3,086 | 3,201 | ||
| 2020-01-02 | Trombly Amy Moss Chief Executive Officer | Grant or award · Stock option (right to buy) | +2,380 | 15,871 | ||
| 2019-12-31 | Trombly Amy Moss Chief Executive Officer | Grant or award · Stock option (right to buy) | +13,491 | 13,491 | ||
| 2019-12-31 | Dal Poggetto John Chief Financial Officer | Grant or award · Stock option (right to buy) | +13,000 | 18,496 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −5,271 | 188,087 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −3,571 | 184,516 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −1,785 | 182,731 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −3,928 | 178,803 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −1,428 | 177,375 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −5,357 | 172,018 | ||
| 2019-01-14 | Schutz James J Former CEO and Former Director | Other disposition · Stock option (right to buy) | −4,285 | 167,733 |
Page 3 of 7 · 127 trades